US Patent Issued to THE UNIVERSITY OF NEW BRUNSWICK on April 21 for "Compositions and methods for inhibiting blood cancer cell growth" (Canadian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,352, issued on April 21, was assigned to THE UNIVERSITY OF NEW BRUNSWICK (Fredericton, Canada).

"Compositions and methods for inhibiting blood cancer cell growth" was invented by Alli Murugesan (Saint John, Canada), Anthony Reiman (Saint John, Canada) and Mohamed Touaibia (Dieppe, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, compositions and uses for inhibiting the growth in blood cancer cells in a patient with one or more of a caffeic acid phenpropyl ester (GL8) analogue selected from the group consisting of As26, J229, J91, LL27, LL23, HM7, As25, MT26, and J205. The blood cancer cells can be myeloma, lymphoma and leukemia cells....